Patents by Inventor Mohammad Reza Ghaderinia

Mohammad Reza Ghaderinia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11187701
    Abstract: A method for diagnosing COVID-19 infection. The method includes drawing a blood sample from a person suspected to be infected with COVID-19 virus, separating a blood serum sample from the blood sample by centrifuging the blood sample, recording an electrochemical impedance spectroscopy (EIS) associated with the blood serum sample, calculating a charge transfer resistance (RCT) of the recorded EIS by measuring a diameter of a semicircular curved part of the recorded EIS, and detecting a COVID-19 infection of the person based on the calculated RCT if the calculated RCT is equal to or more than a threshold value.
    Type: Grant
    Filed: March 20, 2021
    Date of Patent: November 30, 2021
    Inventors: Mohammad Ali Khayamian, Mohammad Abdolahad, Mohammad Salemizadeh Parizi, Mohammad Reza Ghaderinia, Hamed Abadijoo, Shohreh Vanaei, Hossein Simaee, Shahriar Shalileh, Mahsa Faramarzpour Darzini
  • Patent number: 11175255
    Abstract: A system for diagnosing COVID-19 infection. The system includes a biosensor, an electrochemical stimulator-analyzer, and a processing unit. The biosensor is configured to be put in contact with a blood serum sample of a person suspected to be infected of COVID-19 virus. The processing unit is configured to apply an AC potential amplitude to the biosensor while sweeping a frequency range utilizing the electrochemical stimulator-analyzer, recording an electrochemical impedance spectroscopy (EIS) associated with the blood serum sample utilizing the electrochemical stimulator-analyzer, calculating a charge transfer resistance (RCT) of the recorded EIS, and detecting a COVID-19 infection of the person based on the calculated RCT if the calculated RCT is equal to or more than a threshold value.
    Type: Grant
    Filed: March 20, 2021
    Date of Patent: November 16, 2021
    Inventors: Mohammad Ali Khayamian, Mohammad Abdolahad, Mohammad Reza Ghaderinia, Mohammad Salemizadeh Parizi, Hamed Abadijoo, Shohreh Vanaei, Hossein Simaee, Shahriar Shalileh, Mahsa Faramarzpour Darzini
  • Publication number: 20210290832
    Abstract: A method for deactivating circulating cancer cells (CTCs). The method includes reducing viability of CTCs and/or destroying CTCs by applying a positive electrostatic field to bloodstream of a cancer patient.
    Type: Application
    Filed: March 20, 2021
    Publication date: September 23, 2021
    Applicant: Nano Hesgarsazan Salamat Arya
    Inventors: Mohammad Abdolahad, Mohammad Reza Ghaderinia, Mohammad Ali Khayamian, Hamed Abadijoo, Shahriar shalileh
  • Publication number: 20210223244
    Abstract: A method for diagnosing COVID-19 infection. The method includes drawing a blood sample from a person suspected to be infected with COVID-19 virus, separating a blood serum sample from the blood sample by centrifuging the blood sample, recording an electrochemical impedance spectroscopy (EIS) associated with the blood serum sample, calculating a charge transfer resistance (RCT) of the recorded EIS by measuring a diameter of a semicircular curved part of the recorded EIS, and detecting a COVID-19 infection of the person based on the calculated RCT if the calculated RCT is equal to or more than a threshold value.
    Type: Application
    Filed: March 20, 2021
    Publication date: July 22, 2021
    Applicant: Nano Hesgarsazan Salamat Arya
    Inventors: Mohammad Ali Khayamian, Mohammad Abdolahad, Mohammad Salemizadeh Parizi, Mohammad Reza Ghaderinia, Hamed Abadijoo, Shohreh Vanaei, Hossein Siamee, Shahriar Shalileh, Mahsa Faramarzpour Darzini
  • Publication number: 20210223201
    Abstract: A system for diagnosing COVID-19 infection. The system includes a biosensor, an electrochemical stimulator-analyzer, and a processing unit. The biosensor is configured to be put in contact with a blood serum sample of a person suspected to be infected of COVID-19 virus. The processing unit is configured to apply an AC potential amplitude to the biosensor while sweeping a frequency range utilizing the electrochemical stimulator-analyzer, recording an electrochemical impedance spectroscopy (EIS) associated with the blood serum sample utilizing the electrochemical stimulator-analyzer, calculating a charge transfer resistance (RCT) of the recorded EIS, and detecting a COVID-19 infection of the person based on the calculated RCT if the calculated RCT is equal to or more than a threshold value.
    Type: Application
    Filed: March 20, 2021
    Publication date: July 22, 2021
    Applicant: Nano Hesgarsazan Salamat Arya
    Inventors: Mohammad Ali Khayamian, Mohammad Abdolahad, Mohammad Reza Ghaderinia, Mohammad Salemizadeh Parizi, Hamed Abadijoo, Shohreh Vanaei, Hossein Siamee, Shahriar Shalileh, Mahsa Faramarzpour Darzini